Shalamar Institute of Health Sciences

计划入组 70 人 · 首次发布于 2019 年 1 月 11 日

National Institute for Health and Care Research Global Health Research Centre for Multiple Long-Term Conditions

计划入组 3,600 人 · 首次发布于 2026 年 5 月 12 日

Advance Care Planning at London Health Sciences Centre

计划入组 400 人 · 首次发布于 2017 年 9 月 29 日

Gilteritinib-warheaded PROTAC(National Institute of Health Sciences)

OICR-10268

GRP78 inhibitors (Amgen/Cancer Research Technology/Institute of Cancer Research)

AMRITA INSTITUTE OF MEDICAL SCIENCES & RESEARCH CENTRE

India

Health Sciences North Research Institute

Canada

London Health Sciences Centre Research Inc.

Canada

First Health Canada-Approved Phase 2 Trial Investigates Psilocybin Microdosing for Generalized Anxiety Disorder

Personalized Reports on Endocrine-Disrupting Chemicals Reduce Exposure

London Health Sciences Centre Launches Phase II Trial of Internal Radiation Therapy for Kidney Cancer